Propanc Biopharma, Inc. (PPCB) Stock
PPCB Key Statistics
About Propanc Biopharma, Inc.
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
CEO: James Nathanielsz. Company website
PPCB — Frequently Asked Questions
What is the PPCB stock price today?
Propanc Biopharma, Inc. (PPCB) trades at $1.35, down 39.46% on the day, as of Sep 20, 2026 14:58 UTC.
What is Propanc Biopharma, Inc.'s market cap?
Propanc Biopharma, Inc. has a market capitalisation of $20.48M, calculated from the live PPCB share price and shares outstanding.
What is the P/E ratio of PPCB?
PPCB has no meaningful price-to-earnings ratio: Propanc Biopharma, Inc. lost $13.54 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Propanc Biopharma, Inc. make?
Propanc Biopharma, Inc. generated revenue of $29,904.00 over the trailing twelve months, which puts the stock at 684.78 times sales.
What is the 52-week range for PPCB?
PPCB has traded between $0.10 and $6.79 over the past 52 weeks, and the last price is 80.1% below that high.
Is Propanc Biopharma, Inc. profitable?
No. Propanc Biopharma, Inc. is loss-making, with a net margin of -9,999.99% over the trailing twelve months.
What sector is Propanc Biopharma, Inc. in?
Propanc Biopharma, Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in AU .
Who is the CEO of Propanc Biopharma, Inc.?
James Nathanielsz is the chief executive of Propanc Biopharma, Inc., which employs 1 people.
Where can I track PPCB in real time?
QFI Terminal shows PPCB with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See PPCB live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open PPCB in Terminal See plans